Over 500 Myasthenia Gravis patients are using Huma MG Care
Huma MG empowers patients with tools for symptom tracking, education, and proactive care to improve quality of life and reduce healthcare burdens.
Myasthenia Gravis affects daily life and puts patients at risk of exacerbations. Huma MG can help.
Through the Huma Portal, clinicians gain a continuous view of MG patient health and progression-enabling timely intervention, actionable insights, and coordinated appointments and treatment plans.
Huma MG is used across healthcare providers in Europe, United Kingdom and United States
Huma MG leverages Huma's EU MDR Class IIb and FDA Class II regulated Software as a Medical Device (SaMD), evaluated for safety and efficiency.
Patient App
Patients use the HumaMG app (iOS, Android) to access MG-specific educational materials, track symptoms using the MG-ADL questionnaire, and monitor changes over time.
Huma Portal
Care teams use the web-based dashboard to view patient-reported data in real time, detect early signs of exacerbations, identify triggers, and make proactive decisions for personalised care.
Huma MG AI models: A leap in quantifying MG symptoms
First and only FDA-cleared AI-enabled at-home QMG (to be approved in 2026)
Voice assessments, Ptosis, Arm Fatigue
No device needed beyond a smartphone. Model trained on data labelled by leading medical researchers
